期刊文献+
共找到626篇文章
< 1 2 32 >
每页显示 20 50 100
Homogenate extraction technology of camptothecine and hydroxycamptothecin from Camptotheca acuminata leaves 被引量:2
1
作者 史伟国 祖元刚 +1 位作者 赵春建 杨磊 《Journal of Forestry Research》 SCIE CAS CSCD 2009年第2期168-170,I0004,共4页
Camptothecine (CPT) and hydroxycamptothecin (HCPT), two kinds of anti-cancer alkaloids, were extracted from Camptotheca acuminata leaves using homogenate extraction technology under different conditions such as th... Camptothecine (CPT) and hydroxycamptothecin (HCPT), two kinds of anti-cancer alkaloids, were extracted from Camptotheca acuminata leaves using homogenate extraction technology under different conditions such as the ratio of material to liquid, ethanol concentration, and homogenate time. The optimum technology parameters for homogenate extraction of CPT and HCPT from C acuminata leaves were determined as homogenate time at 8 rain, ethanol concentration at 55% and the ratio of material to liquid at 1:15 (g:mL). By using the optimized parameters, we obtained 0.639‰ extraction rate for CPT and 0.437‰ for HCPT. The extraction yields of CPT and HCPT extracted by homogenating technology were higher than those by other extractive methods, such as ultrasonic, reflux, shaking in water bath. It is concluded that the homogenate extraction technology was an efficient method for extracting CPT and HCPT from C acuminata leaves, with characteristics of less extraction time and high yield. 展开更多
关键词 HOMOGENATE Camptotheca acuminata leaves camptothecine hydroxycamptothecin
下载PDF
Determination of contents of 10-Hydroxycamptothecin in Camptotheca acuminata by high-performance liquid chromatogram 被引量:5
2
作者 马梅芳 于涛 +2 位作者 戴绍军 王洋 阎秀峰 《Journal of Forestry Research》 SCIE CAS CSCD 2002年第2期144-146,165,共3页
The determination method of 10-hydroxycamptothecin in Camptotheca acuminata fruits by high-performance liquid chromatogram (HPLC) was studied. The HPLC analysis was performed on a HIQ sil C18(4.6×250 mm) column w... The determination method of 10-hydroxycamptothecin in Camptotheca acuminata fruits by high-performance liquid chromatogram (HPLC) was studied. The HPLC analysis was performed on a HIQ sil C18(4.6×250 mm) column with mobile phase of acetonitrilewater (3:7, V:V), flow rate 1 mLmin-1 and UV detective wavelength 266 nm. Extracting 10-hydroxycamptothecin by ultrasonic method from fruits of C. acuminata to prepare samples for analysis was systematically discussed. The optimal extraction condition was carried out by 60% alcohol solution at 60℃ for 50 minutes. 展开更多
关键词 hydroxycamptothecin Camptotheca acuminata HPLC ultrasonic extraction method
下载PDF
Induction of apoptosis by arsenic trioxide and hydroxycamptothecin in gastric cancer cells in vitro 被引量:43
3
作者 Tu SP Zhong J +4 位作者 Tan JH Jiang XH Qiao MM Wu YX Jiang SH 《World Journal of Gastroenterology》 SCIE CAS CSCD 2000年第4期532-539,共8页
AIM To study the effects of arsenic trioxide andHCPT on different degrees of differentiated gastriccancer cells(SGC-7901,MKN-45,MKN-28)withrespect to both cytotoxicity and induction ofapoptosis in vitro.METHODS The ... AIM To study the effects of arsenic trioxide andHCPT on different degrees of differentiated gastriccancer cells(SGC-7901,MKN-45,MKN-28)withrespect to both cytotoxicity and induction ofapoptosis in vitro.METHODS The cytotoxicity of As<sub>2</sub>O<sub>3</sub> and HCPTon gastric cancer cells was determined by MTTassay.Morphologic changes of apoptosis ofgastric cancer cells were observed by lightmicroscopy and transmission electron microscopy.Apoptosis and cell cycle changes of gastric cancercells induced by HCPT and As<sub>2</sub>O<sub>3</sub> were investigatedby TUNEL method and flow cytometry.RESULTS As<sub>2</sub>O<sub>3</sub> and HCPT had remarkablecytotoxic effects on different degrees ofdifferentiated gastric cancer cells.The IC<sub>50</sub>ofAs<sub>2</sub>O<sub>3</sub> on well differentiated gastric cancer cellMKN-28,moderately differentiated gastric cancercell SGC-7901,and poorly differentiated gastriccancer cell MKN-28 were 8.91 μmol/L,10.57μmol/L,and 11.65 μmol/L,respectively.The IC<sub>50</sub>of HCPT on MKN-28,SGC-7901,and MKN-45 were9.35 mg/L,10.21 mg/L,and 12.63 mg/Lrespectively after 48 h treatment.After 12 h ofexposure to both drugs,gastric cancer cellsexhibited morphologic features of apoptosis,including cell shrinkage,nuclear condensation, and formation of apoptotic bodies.A typicalsubdiploid peak before G<sub>0</sub>/G<sub>1</sub> phase was observedby flow cytometry.The apoptotic rates of SGC-7901,MKN-45,and MKN-28 were 13.84%,22.52%,and 9.68%,respectively after 48 hexposure to 10 μmol/L As<sub>2</sub>O<sub>3</sub>.The apoptotic ratesof SGC-7901,MKN-45,and MKN-28 were 21.88%,12.35%,and 30.26%,respectively after 48 hexposure to 10 mg/L HCPT.The apoptotic indicewere 7%-15% as assessed by TUNEL method.The effect of As<sub>2</sub>O<sub>3</sub> on SGC-7901 showedremarkable cell cycle specificity,which inducedcell death in G<sub>1</sub> phase,and blocked G<sub>2</sub>/M phase.HCPT also showed a remarkable cell cyclespecificity,by inducing cell death and apoptosis inG<sub>1</sub> phase and arrest of proliferation at S phase.CONCLUSION As<sub>2</sub>O<sub>3</sub> and HCPT exhibitsignificant cytotoxicity on gastric cancer cells byinduction of apoptosis.As<sub>2</sub>O<sub>3</sub> and HCPT mighthave a promising prospect in the treatment ofgastric cancer,which needs to be further studied. 展开更多
关键词 GASTRIC cancer APOPTOSIS ARSENIC TRIOXIDE hydroxycamptothecin
下载PDF
Synthesis of 7-Ethyl-10-hydroxycamptothecin and Proposed Reaction Mechanism 被引量:4
4
作者 LEI Ying jie ZHU Chun hua +1 位作者 WANG Zuo quan LIU Hong 《Chemical Research in Chinese Universities》 SCIE CAS CSCD 2001年第1期69-72,共4页
The improved 3 step preparation of a key antitumor agent, 7 ethyl 10 hydroxycamptothecin(SN 38), which consists of ethylation, oxidation and photo chemical rearrangement, is described. The proposed reaction mech... The improved 3 step preparation of a key antitumor agent, 7 ethyl 10 hydroxycamptothecin(SN 38), which consists of ethylation, oxidation and photo chemical rearrangement, is described. The proposed reaction mechanism is also discussed. 展开更多
关键词 Ethyl 10 hydroxycamptothecin(SN 38) Mechanism SYNTHESIS
下载PDF
The short-time effects of chemotherapy with combinations of hydroxycamptothecine and oxaliplatin in treatment of advanced colorectal cancer 被引量:1
5
作者 Yuanjue Sun Hui Zhao Yuewu Guo Feng Lin Xun Cai Xiaochun Tang Yang Yao 《The Chinese-German Journal of Clinical Oncology》 CAS 2007年第1期40-43,共4页
Objective: Although 5-fluarouracil-based chemotherapy has become a standard regimen for treatment of advanced colorectal cancer, the efficacy, as second line therapy, is not high. It is necessary to find a new regime... Objective: Although 5-fluarouracil-based chemotherapy has become a standard regimen for treatment of advanced colorectal cancer, the efficacy, as second line therapy, is not high. It is necessary to find a new regimen as a substitute for these patients. The study was to evaluate the short-time effects and toxicity of combination of HCPT plus L-OHP regimen in treatment of advanced colorectal cancer. Methods: Forty-seven patients with pathological evidence of advanced colorectal cancer were enrolled and were treated with HCPT plus L-OHP regimen for 86 cycles. All patients were treated with L-OHP 130 mg/m^2 day 1 and HCPT 6 mg/m^2day 1-4, the chemotherapy was repeated every 3 weeks as a cycle. The Short-time efficats and side effects were evaluated after 2 cycles for each patient. Results: 38 cases can be evaluated to short-time effects and achieved the overall response rate (CR+PR) was 36.8%. KPS improved in 20 cases (52.6%). In the total 86 cycles, the leucopenia occurred in 59 cycles (68.6%),18 cycles (30.5%) in grade Ⅲ and Ⅳ and the diarrhea occurred in 48 cycles (55.8%), 18 cycles (37.5%) in grade Ⅲ and Ⅳ. Conclusion: A satisfied response rate was obtained in advanced colorectal cancer patients treated by HCPT plus L-OHP regimen, especially who were the failure of first-line chemotherapy with 5-FU. The limited-dose toxicity was leucopenia and diarrhea. 展开更多
关键词 advanced colorectal cancer combined chemotherapy hydroxycamptothecine OXALIPLATIN
下载PDF
Clinical Study of Combining Chemotherapy of Oxaliplatin or 5-Fluorouracil/Leucovorin with Hydroxycamptothecine for Advanced Colorectal Cancer 被引量:1
6
作者 Yuanjue Sun Hui Zhao Yaowu Guo Feng Lin Lina Tang Yang Yao 《Chinese Journal of Clinical Oncology》 CSCD 2009年第2期117-123,共7页
OBJECTIVE To estimate effects, survival rate after the short-time efficacy, side the treatment of combining chemotherapy of oxaliplatin or 5-fluorouracil/leucovorin with hydroxycamptothecine (HCPT) for the patients ... OBJECTIVE To estimate effects, survival rate after the short-time efficacy, side the treatment of combining chemotherapy of oxaliplatin or 5-fluorouracil/leucovorin with hydroxycamptothecine (HCPT) for the patients with advanced colorectal cancer. METHODS From January 2002 to November 2005, 59 patients with advanced colorectal cancer confirmed by pathology were enrolled into this study in the department of medical oncology, in the Sixth People's Hospital of Shanghai Jiaotong University, Shanghai. Patients' characteristics in two groups were similarly confirmed by statistic. All 37 patients in OH group received oxalip21atin (130 mg/m^2 d1) plus hydroxycamptothecine (6 mg/m d1-4), and all 22 patients in the HLF group received hydroxycamptothecine (6 mg/m^2 d1-4) plus leucovorin (300 mg d1-5) and 5-fluorouracil (0.375 g/m^2 d1-5). The regimens in both groups were 21-day cycle that was repeated three weeks. The side effects were evaluated. The efficacy was estimated after two cycles of chemotherapy for each patient. RESULTS The efficacy of the treatment in the OH group with 37 patients and in the HLF group with 22 patients was estimated. The overall response rate (CR + PR) was 32.4% in the OH group and 22.7% in the HLF group. There was no complete response (CR) and there was no statistical significantly difference (%2= 0.876, P = 0.704) in two groups. The 1-year survival rate was 30.98% in the OH group and 15.02% in the HLF group, and it had no significant difference between the two groups. The median PSF and OS were 5.83 months and 11.17 months in the OH group vs. 7.40 months and 10.48 months in the HLF group, and it had no significant differences between the two groups (P 〉 0.05). The major side effects of grade III and IV in the two groups were myelosuppression and gastrointestinal reactions. The statistically significant difference in side effects appeared in leukopenia (χ^2= 17.173, P = 0.001), nausea/vomiting (χ^2= 6.426, P = 0.039), diarrhea (χ^2= 16.245, P = 0.000) and peripheral neuropathy. CONCLUSION The efficacy was almost equal between the OH and the HLF groups, and the two regimens can be used as the second-line treatments for the patients with colorectal cancer. Leucopenia, nausea, diarrhea and peripheral neuropathy appeared more in OH group, and anemia and thrombocytopenia were almost equal between the OH and the HLF groups. 展开更多
关键词 OXALIPLATIN hydroxycamptothecine 5-FLUOROURACIL colorectal cancer.
下载PDF
Homogenate extraction technology of camptothecine and hydroxycamptothecin from Camptotheca acuminata leaves
7
作者 SHI Wei-guo, ZU Yuan-gang, ZHAO Chun-jian, YANG Lei Key Laboratory of Forest Plant Ecology of Ministry of Education, Northeast Forestry University, Harbin 150040, P.R.China 《Journal of Forestry Research》 SCIE CAS CSCD 2009年第A2期168-170,共3页
Camptothecine(CPT) and hydroxycamptothecin(HCPT), two kinds of anti-cancer alkaloids, were extracted from Camptotheca acuminata leaves using homogenate extraction technology under different conditions such as the rati... Camptothecine(CPT) and hydroxycamptothecin(HCPT), two kinds of anti-cancer alkaloids, were extracted from Camptotheca acuminata leaves using homogenate extraction technology under different conditions such as the ratio of material to liquid, ethanol concentration, and homogenate time.The optimum technology parameters for homogenate extraction of CPT and HCPT from C.acuminata leaves were determined as homogenate time at 8 min, ethanol concentration at 55% and the ratio of material to liquid at 1:15(g:mL).By using the optimized parameters, we obtained 0.639‰ extraction rate for CPT and 0.437‰ for HCPT.The extraction yields of CPT and HCPT extracted by homogenating technology were higher than those by other extractive methods, such as ultrasonic, reflux, shaking in water bath.It is concluded that the homogenate extraction technology was an efficient method for extracting CPT and HCPT from C.acuminata leaves, with characteristics of less extraction time and high yield. 展开更多
关键词 HOMOGENATE Camptotheca acuminata leaves camptothecine hydroxycamptothecin
下载PDF
Synthesis and antitumor activity of 9-methyl-10-hydroxycamptothecin
8
作者 Sheng Wang Yu Yan Li Qi Dong You 《Chinese Chemical Letters》 SCIE CAS CSCD 2008年第8期918-920,共3页
A novel camptothecin analogue, 9-methyl-10-hydroxycamptothecin (4), was unexpectedly synthesized from 10-hydroxycamptothecin in two steps. The key step included an efficient Mannich-type reaction. The overall yield ... A novel camptothecin analogue, 9-methyl-10-hydroxycamptothecin (4), was unexpectedly synthesized from 10-hydroxycamptothecin in two steps. The key step included an efficient Mannich-type reaction. The overall yield was 47.2%. An ether analogue of 4, 9-methyl-10-benzylaminomethoxycamptothecin (5), was also prepared. These new camptothecin analogues were evaluated for in vitro cytotoxicity against four human cancer cell lines, and exhibited more potent antitumor activities than contrals camptothecin and topotecan against several cancer cells. 展开更多
关键词 SYNTHESIS CAMPTOTHECIN 10-hydroxycamptothecin CYTOTOXICITY
下载PDF
Polymer Delivery of Hydroxycamptothecin against C6 Glioma
9
作者 Jing Hu Huafei Tang Songqing Liu 《Journal of Cancer Therapy》 2014年第10期920-928,共9页
Hydroxycamptothecin is a potent antineoplastic agent that has shown efficacy against multiple tumor lines in vitro. This is the first study to investigate the release, distribution, and efficacy of hydroxycamptothecin... Hydroxycamptothecin is a potent antineoplastic agent that has shown efficacy against multiple tumor lines in vitro. This is the first study to investigate the release, distribution, and efficacy of hydroxycamptothecin which was incorporated into the biodegradable polymer Polylactic Acid (PLA), and implant into brain directly. In vitro release curve generated showed that a large initial release occurred over the first three days and was followed by a steady, but considerably slower rate of release over the next 25 days. After implanting the discs into 40 male SD rats, the animals were followed up to 28 days, where the concentration in brain tissue was far higher than that in peripheral blood at the each of the eight time-points evaluated, and it was also within the therapeutic range for C6 cells tested in vitro. The in vivoefficacy of the discs was evaluated with rats inoculated intracranially with C6 glioma and treated with hydroxycamptothecin polymer compared to intravenous as well as intratumoral injections;the median survival is 21.1, 13.9, 14.9 days, respectively. Given these data, we conclude that the biodegradable polymer PLA releases hydroxycamptothecin, producing tumoricidal levels in brain tissues and prolonging survival in a rat glioma model. 展开更多
关键词 hydroxycamptothecin Polylactic ACID (PLA) C6 GLIOMA SUSTAINED Release
下载PDF
Development and Validation of Stability Indicating LC Method for 10-Hydroxycamptothecin
10
作者 Arala Venkateshwarlu A. V. Rama Rao Khagga Mukkanti 《American Journal of Analytical Chemistry》 2012年第7期470-477,共8页
The present method gives a detailed description for the development and validation of a simple stability indicating reverse phase liquid chromatographic method for 10-hydroxycamptothecin(10-HCTN) in the presence of it... The present method gives a detailed description for the development and validation of a simple stability indicating reverse phase liquid chromatographic method for 10-hydroxycamptothecin(10-HCTN) in the presence of its impurities namely Imp A and Imp B along with degradation products generated from forced degradation studies. The drug was subjected to stress conditions of hydrolysis (acid, base and neutral), oxidative, photolytic and thermal stress degradation. Degradation was observed when subjected to treatment with peroxides or under conditions normally used for typical acid and base hydrolysis. The drug was found to be stable under other stress conditions attempted such as photolytic and thermal. Successful separation and isolation of the drug from related impurities and degradation products formed under stress conditions was achieved on an Inertsil ODS-3V (250 mm × 4.6 mm, 5 μm) column using a phosphate buffer, acetonitrile, methanol and Nanopure water. The developed HPLC method was validated with respect to specificity, linearity, accuracy, precision, sensitivity, robustness and solution stability. The assay method was found to be linear in the range of 0.16 mg/mL to 0.24 mg/mL with a correlation coefficient of 0.999 and the linearity of the impurities was established from 0.02% (LOQ) to 0.3%. Recoveries of assay and impurities were found between 99.4% and 100.3%. The developed HPLC method can be used to determine the related substances and assay determinations of 10-HCTN and also to evaluate the quality and long term stability of production samples. 展开更多
关键词 10-hydroxycamptothecin HPLC METHOD VALIDATION DEGRADATION ANTI-CANCER Activity and Related Substances
下载PDF
基于羟乙基淀粉-姜黄素前药的SN38协同给药胶束构建与评价
11
作者 王子丹 韩银磊 +2 位作者 彭虎红 关怡新 姚善泾 《高校化学工程学报》 EI CAS CSCD 北大核心 2024年第4期608-615,共8页
化疗药物协同给药可以作用于不同代谢通路,有效抑制癌细胞增殖,从而改善药物的治疗效果,在避免引发多药耐药性等方面具有显著优势。本研究基于季铵盐羟乙基淀粉-姜黄素(QHES-S-CUR)前药,构建了负载7-乙基-10-羟基喜树碱(SN38)的协同给... 化疗药物协同给药可以作用于不同代谢通路,有效抑制癌细胞增殖,从而改善药物的治疗效果,在避免引发多药耐药性等方面具有显著优势。本研究基于季铵盐羟乙基淀粉-姜黄素(QHES-S-CUR)前药,构建了负载7-乙基-10-羟基喜树碱(SN38)的协同给药胶束SN38@QHES-S-CUR。首先,借助分子动力学模拟的手段预测姜黄素与SN38共混体系的稳定性;在此基础上,通过纳米沉淀法制备了负载SN38的协同给药胶束。详细考察了QHES-S-CUR与SN38的质量比对胶束形貌及粒径分布的影响,在QHES-S-CUR与SN38的质量比为20:1时,可得到平均粒径为(258.76±28.76)nm的球形纳米粒。体外药物释放实验表明,SN38@QHES-S-CUR胶束能够在模拟的肿瘤微环境中响应性地释放出姜黄素及SN38,比SN38单独给药对小鼠结肠癌细胞CT-26的细胞毒性显著增强。本研究将两亲性前药应用于疏水性化疗药物的递送中,为化疗药物的协同给药提供了新思路。 展开更多
关键词 羟乙基淀粉 姜黄素 7-乙基-10-羟基喜树碱 前药 协同给药 胶束
下载PDF
基于玉米醇溶蛋白-透明质酸载体的结肠靶向口服纳米药物研究
12
作者 朱曙霞 王美玲 +3 位作者 许紫宁 庾远龙 潘建林 汪红娣 《杭州师范大学学报(自然科学版)》 CAS 2024年第2期113-123,共11页
设计基于玉米醇溶蛋白(Zein)-透明质酸(HA)的口服纳米载体用于结肠靶向的药物递送.使用超声透析法制备玉米醇溶蛋白-透明质酸-羟基喜树碱(HCPT)纳米药物(Zein-HA@HCPT),利用渴望函数分析法优化纳米药物制备条件,考察纳米药物的微结构、... 设计基于玉米醇溶蛋白(Zein)-透明质酸(HA)的口服纳米载体用于结肠靶向的药物递送.使用超声透析法制备玉米醇溶蛋白-透明质酸-羟基喜树碱(HCPT)纳米药物(Zein-HA@HCPT),利用渴望函数分析法优化纳米药物制备条件,考察纳米药物的微结构、药物释放行为、细胞毒性和靶向摄取能力.Zein-HA@HCPT具有95%以上的药物包封率,有优异的生物学稳定性、生物相容性和独特的抗胃酸分解特性,结肠环境下的药物累积释放显著提升.Zein-HA@HCPT通过CD44受体介导的内吞作用被结肠癌细胞靶向摄取,可提高药物抗肿瘤疗效. 展开更多
关键词 玉米醇溶蛋白 透明质酸 羟基喜树碱 结肠靶向
下载PDF
Menthol-modified casein nanoparticles loading 10-hydroxycamptothecin for glioma targeting therapy 被引量:15
13
作者 Caifang Gao Jianming Liang +6 位作者 Ying Zhu Chengli Ling Zhekang Cheng Ruixiang Li Jing Qin Weigen Lu Jianxin Wang 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2019年第4期843-857,共15页
Chemotherapy outcomes for the treatment of glioma remains unsatisfactory due to the inefficient drug transport across the blood–brain barrier(BBB) and insufficient drug accumulation in the tumor region. Although many... Chemotherapy outcomes for the treatment of glioma remains unsatisfactory due to the inefficient drug transport across the blood–brain barrier(BBB) and insufficient drug accumulation in the tumor region. Although many approaches, including various nanosystems, have been developed to promote the distribution of chemotherapeutics in the brain tumor, the delivery efficiency and the possible damage to the normal brain function still greatly restrict the clinical application of the nanocarriers.Therefore, it is urgent and necessary to discover more safe and effective BBB penetration and gliomatargeting strategies. In the present study, menthol, one of the strongest BBB penetration enhancers screened from traditional Chinese medicine, was conjugated to casein, a natural food protein with brain targeting capability. Then the conjugate self-assembled into the nanoparticles to load anti-cancer drugs.The nanoparticles were characterized to have appropriate size, spheroid shape and high loading drug capacity. Tumor spheroid penetration experiments demonstrated that penetration ability of mentholmodified casein nanoparticles(M-CA-NP) into the tumor were much deeper than that of unmodified nanoparticles. In vivo imaging further verified that M-CA-NPs exhibited higher brain tumor distribution than unmodified nanoparticles. The median survival time of glioma-bearing mice treated with HCPT-MCA-NPs was significantly prolonged than those treated with free HCPT or HCPT-CA-NPs. HE staining ofthe organs indicated the safety of the nanoparticles. Therefore, the study combined the advantages of traditional Chinese medicine strategy with modern delivery technology for brain targeting, and provide a safe and effective approach for glioma therapy. 展开更多
关键词 GLIOMA CASEIN MENTHOL NANOPARTICLES BRAIN targeting Blood–brain barrier 10-hydroxycamptothecin
原文传递
甘草酸、姜黄素和羟基喜树碱自组装纳米粒递药系统的工艺优化研究
14
作者 冯丽珍 黄锦平 +7 位作者 刘胜君 王瑶 黄冬怡 黄婷婷 廖伟菊 邓润芳 黄兴振 靳荣华 《广西医科大学学报》 CAS 2024年第4期598-607,共10页
目的:以两亲性药物分子甘草酸(GA)、疏水性药物姜黄素(CUR)和羟基喜树碱(HCPT)为材料,通过自组装形式构建GA、CUR和HCPT纳米粒递药系统(GA/CUR/HCPT-NPs),考察其制备工艺并进行质量评价。方法:采用反溶剂沉淀法和透析法相结合制备GA/CUR... 目的:以两亲性药物分子甘草酸(GA)、疏水性药物姜黄素(CUR)和羟基喜树碱(HCPT)为材料,通过自组装形式构建GA、CUR和HCPT纳米粒递药系统(GA/CUR/HCPT-NPs),考察其制备工艺并进行质量评价。方法:采用反溶剂沉淀法和透析法相结合制备GA/CUR/HCPT-NPs,利用响应面Box-Behnken法对制备工艺进行优化,最终获得尺寸合适,稳定电荷,高载药量的GA/CUR/HCPT-NPs;并对优化出来的GA/CUR/HCPT-NPs进行核磁共振氢谱(1HNMR)、差示扫描量热法(DSC)、高分辨X射线衍射法(XRD)、傅里叶红外分光光度法(FTIR)、紫外分光光度法(UV)等表征和微观形态观察,并测定GA/CUR/HCPT-NPs中GA、CUR和HCPT含量大小。结果:得到的最优处方为去离子水体积30 mL,二甲基亚砜(DMSO)1 min内滴入去离子水,制备温度为40℃,确定GA、CUR、HCPT投药量分别为6.00 mg、10.03 mg、5.01 mg;测量GA/CUR/HCPT-NPs粒径为(146.37±0.15)nm,且带较高的稳定电荷-(34.43±0.77)mV,PDI为0.157±0.01,透射电子显微镜(TEM)和扫描电子显微镜(SEM)可观察到GA/CUR/HCPT-NPs是类球形或球形,并且均匀分布;1HNMR、DSC、XRD等证明了成功自组装成稳定的GA/CUR/HCPT-NPs,并且在7 d内4℃保存条件下稳定性良好;高效液相色谱(HPLC)测定GA/CUR/HCPT-NPs中GA、CUR、HCPT的载药量分别为57.19%、39.17%和3.07%。结论:本研究通过优化的反溶剂沉淀法结合透析法成功制备尺寸合适、均匀分布的GA/CUR/HCPT-NPs,为进一步实验奠定了基础。 展开更多
关键词 羟基喜树碱 姜黄素 甘草酸 无载体绿色纳米递药系统 工艺优化
下载PDF
Oxaliplatin plus hydroxycamptothecine versus oxaliplatin plus 5-fluorouracil and leucovorin in treatment of advanced colorectal cancer 被引量:1
15
作者 YAO Yang SUN Yuan-jue +6 位作者 ZHAO Hui GUO Yue-wu LIN Feng CAI Xun TANG Xiao-chun TANG Li-na ZHANG Wei 《Chinese Medical Journal》 SCIE CAS CSCD 2006年第21期1829-1833,共5页
5-fluarouracil-based chemotherapy has become a standard regimen for the treatment of advanced colorectal cancer (ACRC).^1 Defined as the second line therapy for ACRC with 5-fluarouracil (5-Fu) plus leucovorin (LV... 5-fluarouracil-based chemotherapy has become a standard regimen for the treatment of advanced colorectal cancer (ACRC).^1 Defined as the second line therapy for ACRC with 5-fluarouracil (5-Fu) plus leucovorin (LV) combined with oxaliplatin (OXA), the response rate (RR), progression-free survival (PFS) and overall survival (OS) were 21.2%, at 4.7 and 11.5 months, whereas RR, PFS and OS with 5-Fu plus LV combined with irinotecan (CPT-11) were 11.4%, at 3.2 and 12.2 months. There were no statistical difference between the two protocals.^2,3 Those results may well suggest that some of these patients were resistant to 5-Fu. Therefore it is necessary to find a more effective regimen without 5-Fu to treat recurrent ACRC patients that were initially treated with 5-Fu. Our previous study showed that OXA can enhance the function of hydroxycamptothecine (HCPT) in inducing the apoptosis of a human colorectal cell line in vivo.^4 So we chose OXA plus HCPT (OH) regimen to treat 28 patients with ACRC and compared RR, one-year survival rate, PFS, OS and main toxicities with a 5-Fu plus LV combined with OXA (OFL) regimen. 展开更多
关键词 colorectal cancer hydroxycamptothecine OXALIPLATIN
原文传递
羟基喜树碱铁蛋白包合物的制备及其抗结肠癌活性的研究
16
作者 刘玉娇 杨静 +3 位作者 罗静远 李雪 周四元 刘道洲 《西北药学杂志》 CAS 2024年第4期93-99,共7页
目的用铁蛋白(ferritin,Fn)包合羟基喜树碱(hydroxycamptothecin,HCPT)制备羟基喜树碱铁蛋白包合物(hydroxycamptothecin@ferritin,HCPT@Fn),增加HCPT的溶解性,提高治疗结肠癌的效果。方法用透析法制备HCPT@Fn;用激光粒度测定仪检测HCPT... 目的用铁蛋白(ferritin,Fn)包合羟基喜树碱(hydroxycamptothecin,HCPT)制备羟基喜树碱铁蛋白包合物(hydroxycamptothecin@ferritin,HCPT@Fn),增加HCPT的溶解性,提高治疗结肠癌的效果。方法用透析法制备HCPT@Fn;用激光粒度测定仪检测HCPT@Fn的粒径及Zeta电位;用超高效液相色谱法(ultra-high performance liquid chromatography,UPLC)检测HCPT@Fn中HCPT的载药量;用3-(4,5-二甲基噻唑-2)-2,5-二苯基四氮唑溴盐[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide,MTT]实验、活死细胞染色实验及克隆形成实验考察HCPT@Fn对人结肠癌细胞(human colon cancer cells,HT-29)的毒性;用荧光显微镜观察HCPT@Fn在HT-29细胞内的蓄积;用溶血实验及HE染色实验初步考察HCPT@Fn的安全性。结果用透析法制备的HCPT@Fn的粒径为148.4 nm,Zeta电位为−34.4 mV,载药量为37.46%;HCPT@Fn能大量蓄积于HT-29细胞中,可显著抑制HT-29细胞的增殖及克隆形成;在设定的质量浓度范围内,HCPT@Fn均未造成明显的溶血,HCPT@Fn对小鼠正常组织无明显破坏性。结论HCPT@Fn能够显著增加HCPT的溶解性,提高抗结肠癌活性并降低毒性和不良反应。 展开更多
关键词 羟基喜树碱 铁蛋白 包合物 结肠癌 化疗
下载PDF
Hydroxycamptothecine and Cantharidin Combined with Cisplatinand Lipiodol Through Transcatheter Arterial Embolizalionin Hepatocellular Carcinoma
17
作者 于志坚 孟宪镛 +1 位作者 徐克成 葛政举 《Chinese Journal of Integrative Medicine》 SCIE CAS 1995年第3期175-178,共4页
Transcatheter arterial embolization with hydroxycamptothecine, cantharidin and cisplatin,thoroughly mixed with large doses of interferon and interleukin-2, was performed in 48 cases with unre-sectable intermediate or ... Transcatheter arterial embolization with hydroxycamptothecine, cantharidin and cisplatin,thoroughly mixed with large doses of interferon and interleukin-2, was performed in 48 cases with unre-sectable intermediate or advanced hepatocellular carcinoma. The results demonstrate a partial remissionrate of 54. 2%, significantly higher than that in embolization with chemotherapeutic agents alone (cis-platin, adriamycin and mitomycin, 32. 1%, P<O. 01) . Morever, the adverse reactions of hydroxycamp-tothecine and cantharidin, when applied systemically, including hematuria or urodynia were successfullyeliminated. 展开更多
关键词 hydroxycamptothecine. cantharidin hepatocellular carcinoma transcatheter arterialembolization
原文传递
10-羟基喜树碱对非小细胞肺癌上皮-间质转化的影响
18
作者 叶竹钦 《海峡药学》 2024年第6期23-28,共6页
目的研究10-羟基喜树碱(hydroxycamptothecin,HCPT)对人非小细胞肺癌细胞(A549)上皮-间质转化(EMT)的影响,为后续的分子水平研究奠定基础。方法实验组分为常氧组和低氧组,其中低氧组以100μmol·L^(-1) CoCl 2溶液,低氧诱导24 h,使A... 目的研究10-羟基喜树碱(hydroxycamptothecin,HCPT)对人非小细胞肺癌细胞(A549)上皮-间质转化(EMT)的影响,为后续的分子水平研究奠定基础。方法实验组分为常氧组和低氧组,其中低氧组以100μmol·L^(-1) CoCl 2溶液,低氧诱导24 h,使A549细胞产生上皮-间质转化。通过MTT细胞毒性实验、划痕实验、transwell实验、形态学显微观察HCPT对A549细胞的形态、迁移能力、侵袭能力的影响。结果通过MTT实验测得HCPT作用于A549细胞24 h后的IC 50=75.284μmol·L^(-1);HCPT能够显著抑制A549细胞的迁移能力和侵袭能力,并且细胞的间质形态特征得到显著抑制甚至是逆转。结论10-羟基喜树碱对人非小细胞肺癌细胞的上皮-间质转化起抑制作用。 展开更多
关键词 10-羟基喜树碱 非小细胞肺癌 氯化钴低氧诱导 上皮-间质转化
下载PDF
Spectroscopic Investigation of the Interaction between Human Serum Albumins and 10-Hydroxycamptothecin
19
作者 LI Guizhi LIU Yongming 《Wuhan University Journal of Natural Sciences》 CAS 2009年第3期257-261,共5页
The binding reaction between 10-hydroxycamptothecin (10-HCPT) and human serum albumins (HSA) is studied by means of fluorescence spectroscopy, UV-Vis absorption spectrum, IH NMR spectrum, and molecular simulation.... The binding reaction between 10-hydroxycamptothecin (10-HCPT) and human serum albumins (HSA) is studied by means of fluorescence spectroscopy, UV-Vis absorption spectrum, IH NMR spectrum, and molecular simulation. The results indicate that the binding reaction of 10-HCPT and HSA is a single static quenching process, and the binding equilibrium constant for 10-HCPT binding with HSA is estimated K0-4.93×10^4 L · mol-I at 25 ℃ with the molar ratio of I : 1. The distance (r) and energy transfer efficiency(E) between donor (HSA) and acceptor (10-HCPT) are obtained as follows, r=3.51 nm; E-0.27. The enthalpy change (△Hφ) and entropy change (△Sφ) are calcu- lated at different temperatures, and the hydrophobic force and shidipole force are the functions in the reaction. The results show that 10-HCPT binds within the subdomain II A of HSA by the hydrophobic force, and the 10-OH and 20-OH of 10-HCPT bind with both residue Leu-238 of HSA and Ala 291 of HSA by hydrogen bonds. 展开更多
关键词 10-hydroxycamptothecin human serum albumins (HSA) fluorescence spectroscopy UV absorption spectroscopy 1H NMR spectrum molecular simulation
原文传递
羟基喜树碱脂质体调节SphK1/S1P信号通路对心力衰竭大鼠心肌纤维化的影响
20
作者 李思阳 李更东 闫宇辉 《中山大学学报(医学科学版)》 CAS CSCD 北大核心 2023年第5期801-808,共8页
【目的】探讨羟基喜树碱脂质体(LHCPT)调节鞘氨醇激酶1(SphK1)/1-磷酸鞘氨醇(S1P)信号通路对心力衰竭大鼠心肌纤维化的影响。【方法】SD大鼠分为对照组、模型组、羟基喜树碱(HCPT)组、LHCPT组、卡托普利组、LHCPT+K6PC-5(SphK1激活剂)组... 【目的】探讨羟基喜树碱脂质体(LHCPT)调节鞘氨醇激酶1(SphK1)/1-磷酸鞘氨醇(S1P)信号通路对心力衰竭大鼠心肌纤维化的影响。【方法】SD大鼠分为对照组、模型组、羟基喜树碱(HCPT)组、LHCPT组、卡托普利组、LHCPT+K6PC-5(SphK1激活剂)组,每组12只。除对照组外,其他组大鼠均需通过腹腔注射阿霉素的方法构建心力衰竭大鼠模型,建模成功后,进行给药处理,给药一天一次,持续4周。彩色多普勒超声仪检测大鼠左室收缩末期内径(LVESD)、左室舒张末期内径(LVEDD)、左室射血分数(LVEF);HE、Masson染色分别检测大鼠心肌组织病理损伤、心肌纤维化;ELISA法检测大鼠心肌组织中肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)水平;qRT-PCR检测大鼠心肌组织中转化生长因子-β1(TGF-β1)、I型胶原蛋白(Collagen I)、Ⅲ型胶原蛋白(CollagenⅢ)表达;Western blot检测大鼠心肌组织中SphK1、S1P蛋白表达。【结果】与对照组比较,模型组大鼠心肌组织病理损伤及纤维化严重,LVESD、LVEDD、TNF-α、IL-6水平、TGF-β1、Collagen I、CollagenⅢmRNA表达及SphK1、S1P蛋白表达升高,LVEF降低(P<0.05);与模型组比较,HCPT组、LHCPT组、卡托普利组大鼠心肌组织病理损伤及纤维化减轻,LVESD、LVEDD、TNF-α、IL-6水平、TGF-β1、CollagenⅠ、CollagenⅢmRNA表达及SphK1、S1P蛋白表达降低,LVEF升高(P<0.05);与LHCPT组比较,LHCPT+K6PC-5组大鼠心肌组织病理损伤及纤维化加剧,LVESD、LVEDD、TNF-α、IL-6水平、TGF-β1、CollagenⅠ、CollagenⅢmRNA表达及SphK1、S1P蛋白表达升高,LVEF降低(P<0.05)。【结论】LHCPT可能通过抑制SphK1/S1P信号通路抑制心力衰竭大鼠心肌纤维化。 展开更多
关键词 羟基喜树碱脂质体 心力衰竭 鞘氨醇激酶1/1-磷酸鞘氨醇信号通路 心肌纤维化
下载PDF
上一页 1 2 32 下一页 到第
使用帮助 返回顶部